References
- Nicoll RA. A brief history of long-term potentiation. Neuron. 2017;93(2):281–290.
- Battaglia F, Wang HY, Ghilardi MF, et al. Cortical plasticity in Alzheimer’s disease in humans and rodents. Biol Psychiatry. 2007;62(12):1405–1412.
- Pinho J, Vale R, Batalha VL, et al. Enhanced LTP in aged rats: detrimental or compensatory? Neuropharmacology. 2017;114:12–19.
- Korz V, Frey JU. Emotional and cognitive reinforcement of rat hippocampal long-term potentiation by different learning paradigms. Neuron Glia Biol. 2004;1(3):253–261.
- Kikusui T, Aoyagi A, Kaneko T. Spatial working memory is independent of hippocampal CA1 long-term potentiation in rats. Behav Neurosci. 2000;114(4):700–706.
- Yamamoto T, Jin J, Watanabe S. Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav Brain Res. 1997;83(1–2):57–62.
- Berde B, Schild HO, editors. Ergot alkaloids and related compounds. Vol. 49, Handbook of experimental pharmacology. Berlin: Springer; 1978.
- Doralp S, Leung LS. Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation. Neurobiol Learn Mem. 2008;90(2):382–388.
- Huang Q, Zhou D, Chase K, et al. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Natl Acad Sci USA. 1992;89(24):11988–11992.
- Ljungberg T, Apicella P, Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. J Neurophysiol. 1992;67(1):145–163.
- Li S, Cullen WK, Anwyl R, et al. Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nat Neurosci. 2003;6(5):526–531.
- Otani S, Bai J, Blot K. Dopaminergic modulation of synaptic plasticity in rat prefrontal neurons. Neurosci Bull. 2015;31(2):183–190.
- Hotte M, Naudon L, Jay TM. Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats. Neurobiol Learn Mem. 2005;84(2):85–92.
- Bobkova NV, Medvinskaya NI, Nesterova IV, et al. Lesioning of spatial memory in mice treated with agroclavin. Neurosci Behav Physiol. 2003;33(4):301–306.
- Bobkova N, Vorobyov V, Medvinskaya N, et al. Interhemispheric EEG differences in olfactory bulbectomized rats with different cognitive abilities and brain beta-amyloid levels. Brain Res. 2008;1232:185–194.
- Vepritskaya IG, Boichenko LV, Arinbasarov MU, et al. Selection of ergot alkaloid producers by induced mutagenesis. Appl Biochem Microbiol. 2002;38(1):28–31.
- Ondrejcak T, Klyubin I, Hu NW, et al. Alzheimer’s disease amyloid beta-protein and synaptic function. Neuromol Med. 2010;12(1):13–26.
- McGurk SR, Levin ED, Butcher LL. Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav Neural Biol. 1988;49(2):234–239.
- Nalbantoglu J, Tirado-Santiago G, Lahsaïni A, et al. Impaired learning and LTP in mice expressing the carboxyterminus of the Alzheimer amyloid precursor protein. Nature. 1997;387(6632):500–505.,
- Yamazaki Y, Jia Y, Hamaue N, et al. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci. 2005;22(4):845–860.
- Carlsen J, De Olmos J, Heimer L. Tracing of the two-neuron pathways in the olfactory system by the aid of transneuronal degeneration. Projections to the amygdaloid body and hippocampal formation. J Comp Neurol. 1982;208(2):196–208.
- Moriguchi S, Han F, Nakagawasai O, et al. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J Neurochem. 2006;97(1):22–29.
- Welsby PJ, Rowan MJ, Anwyl R. Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. Eur J Neurosci. 2009;29(1):65–75.
- Chen YG. Research progress in the pathogenesis of Alzheimer’s disease. Chin Med J (Engl). 2018;131(13):1618–1624.
- Luo J, Lee SH, VandeVrede L, et al. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Mol Neurodegener. 2016;11:35.